Risk Factors Associated With Transition From Acute to Chronic Low Back Pain in US Patients Seeking Primary Care

Joel M Stevans, Anthony Delitto, Samannaaz S Khoja, Charity G Patterson, Clair N Smith, Michael J Schneider, Janet K Freburger, Carol M Greco, Jennifer A Freel, Gwendolyn A Sowa, Ajay D Wasan, Gerard P Brennan, Stephen J Hunter, Kate I Minick, Stephen T Wegener, Patti L Ephraim, Michael Friedman, Jason M Beneciuk, Steven Z George, Robert B Saper, Joel M Stevans, Anthony Delitto, Samannaaz S Khoja, Charity G Patterson, Clair N Smith, Michael J Schneider, Janet K Freburger, Carol M Greco, Jennifer A Freel, Gwendolyn A Sowa, Ajay D Wasan, Gerard P Brennan, Stephen J Hunter, Kate I Minick, Stephen T Wegener, Patti L Ephraim, Michael Friedman, Jason M Beneciuk, Steven Z George, Robert B Saper

Abstract

Importance: Acute low back pain (LBP) is highly prevalent, with a presumed favorable prognosis; however, once chronic, LBP becomes a disabling and expensive condition. Acute to chronic LBP transition rates vary widely owing to absence of standardized operational definitions, and it is unknown whether a standardized prognostic tool (ie, Subgroups for Targeted Treatment Back tool [SBT]) can estimate this transition or whether early non-guideline concordant treatment is associated with the transition to chronic LBP.

Objective: To assess the associations between the transition from acute to chronic LBP with SBT risk strata; demographic, clinical, and practice characteristics; and guideline nonconcordant processes of care.

Design, setting, and participants: This inception cohort study was conducted alongside a multisite, pragmatic cluster randomized trial. Adult patients with acute LBP stratified by SBT risk were enrolled in 77 primary care practices in 4 regions across the United States between May 2016 and June 2018 and followed up for 6 months, with final follow-up completed by March 2019. Data analysis was conducted from January to March 2020.

Exposures: SBT risk strata and early LBP guideline nonconcordant processes of care (eg, receipt of opioids, imaging, and subspecialty referral).

Main outcomes and measures: Transition from acute to chronic LBP at 6 months using the National Institutes of Health Task Force on Research Standards consensus definition of chronic LBP. Patient demographic characteristics, clinical factors, and LBP process of care were obtained via electronic medical records.

Results: Overall, 5233 patients with acute LBP (3029 [58%] women; 4353 [83%] White individuals; mean [SD] age 50.6 [16.9] years; 1788 [34%] low risk; 2152 [41%] medium risk; and 1293 [25%] high risk) were included. Overall transition rate to chronic LBP at six months was 32% (1666 patients). In a multivariable model, SBT risk stratum was positively associated with transition to chronic LBP (eg, high-risk vs low-risk groups: adjusted odds ratio [aOR], 2.45; 95% CI, 2.00-2.98; P < .001). Patient and clinical characteristics associated with transition to chronic LBP included obesity (aOR, 1.52; 95% CI, 1.28-1.80; P < .001); smoking (aOR, 1.56; 95% CI, 1.29-1.89; P < .001); severe and very severe baseline disability (aOR, 1.82; 95% CI, 1.48-2.24; P < .001 and aOR, 2.08; 95% CI, 1.60-2.68; P < .001, respectively) and diagnosed depression/anxiety (aOR, 1.66; 95% CI, 1.28-2.15; P < .001). After controlling for all other variables, patients exposed to 1, 2, or 3 nonconcordant processes of care within the first 21 days were 1.39 (95% CI, 1.21-2.32), 1.88 (95% CI, 1.53-2.32), and 2.16 (95% CI, 1.10-4.25) times more likely to develop chronic LBP compared with those with no exposure (P < .001).

Conclusions and relevance: In this cohort study, the transition rate to chronic LBP was substantial and increased correspondingly with SBT stratum and early exposure to guideline nonconcordant care.

Conflict of interest statement

Conflict of Interest Disclosures: Dr Delitto reported receiving grants from the National Institutes of Health outside the submitted work. Dr Sowa reported receiving grants from the National Institutes of Health outside the submitted work. Dr George reported receiving grants from the National Institutes of Health and receiving personal fees from Rehab Essentials and MedRisk outside the submitted work. No other disclosures were reported.

Figures

Figure 1.. Flow Diagram Depicting Patient Screening…
Figure 1.. Flow Diagram Depicting Patient Screening for Acute Low Back Pain (LBP) and 6-Month Survey in the Targeted Interventions to Prevent Chronic Low Back Pain in High-Risk Patients (TARGET) Trial
Patients who were identified at baseline as having low and medium risk were only included in the observational component of the TARGET study. Patients screened as high risk were included in the observational and the cluster randomized trial component of the TARGET study. In the cluster randomized trial, patients received either usual care or the intervention (usual care with psychologically informed physical therapy) depending on the clinic where they presented.
Figure 2.. Questionnaire to Classify Acute vs…
Figure 2.. Questionnaire to Classify Acute vs Chronic Low Back Pain
This questionnaire has been adapted from the National Institutes of Health Task Force on Research Standards for Chronic Low Back Pain definition. Q indicates question.

References

    1. Global Burden of Disease Collaborative Network Global Burden of Disease Study 2017 (GBD 2017) results. Accessed January 11, 2021.
    1. Von Korff M, Scher AI, Helmick C, et al. . United States National Pain Strategy for population research: concepts, definitions, and pilot data. J Pain. 2016;17(10):1068-1080. doi:10.1016/j.jpain.2016.06.009
    1. Dahlhamer J, Lucas J, Zelaya C, et al. . Prevalence of chronic pain and high-impact chronic pain among adults—United States, 2016. MMWR Morb Mortal Wkly Rep. 2018;67(36):1001-1006. doi:10.15585/mmwr.mm6736a2
    1. Dieleman JL, Cao J, Chapin A, et al. . US health care spending by payer and health condition, 1996-2016. JAMA. 2020;323(9):863-884. doi:10.1001/jama.2020.0734
    1. Kim LH, Vail D, Azad TD, et al. . Expenditures and health care utilization among adults with newly diagnosed low back and lower extremity pain. JAMA Netw Open. 2019;2(5):e193676. doi:10.1001/jamanetworkopen.2019.3676
    1. Pengel LH, Herbert RD, Maher CG, Refshauge KM. Acute low back pain: systematic review of its prognosis. BMJ. 2003;327(7410):323. doi:10.1136/bmj.327.7410.323
    1. Koes BW, van Tulder MW, Thomas S. Diagnosis and treatment of low back pain. BMJ. 2006;332(7555):1430-1434. doi:10.1136/bmj.332.7555.1430
    1. Mehling WE, Gopisetty V, Bartmess E, et al. . The prognosis of acute low back pain in primary care in the United States: a 2-year prospective cohort study. Spine (Phila Pa 1976). 2012;37(8):678-684. doi:10.1097/BRS.0b013e318230ab20
    1. Itz CJ, Geurts JW, van Kleef M, Nelemans P. Clinical course of non-specific low back pain: a systematic review of prospective cohort studies set in primary care. Eur J Pain. 2013;17(1):5-15. doi:10.1002/j.1532-2149.2012.00170.x
    1. Chou R, Shekelle P. Will this patient develop persistent disabling low back pain? JAMA. 2010;303(13):1295-1302. doi:10.1001/jama.2010.344
    1. Deyo RA, Dworkin SF, Amtmann D, et al. . Report of the NIH Task Force on research standards for chronic low back pain. J Pain. 2014;15(6):569-585. doi:10.1016/j.jpain.2014.03.005
    1. Hill JC, Whitehurst DG, Lewis M, et al. . Comparison of stratified primary care management for low back pain with current best practice (STarT Back): a randomised controlled trial. Lancet. 2011;378(9802):1560-1571. doi:10.1016/S0140-6736(11)60937-9
    1. Foster NE, Mullis R, Hill JC, et al. ; IMPaCT Back Study team . Effect of stratified care for low back pain in family practice (IMPaCT Back): a prospective population-based sequential comparison. Ann Fam Med. 2014;12(2):102-111. doi:10.1370/afm.1625
    1. Hill JC, Dunn KM, Main CJ, Hay EM. Subgrouping low back pain: a comparison of the STarT Back Tool with the Orebro Musculoskeletal Pain Screening Questionnaire. Eur J Pain. 2010;14(1):83-89. doi:10.1016/j.ejpain.2009.01.003
    1. Koes BW, van Tulder MW, Ostelo R, Kim Burton A, Waddell G. Clinical guidelines for the management of low back pain in primary care: an international comparison. Spine (Phila Pa 1976). 2001;26(22):2504-2513. doi:10.1097/00007632-200111150-00022
    1. Koes BW, van Tulder M, Lin CW, Macedo LG, McAuley J, Maher C. An updated overview of clinical guidelines for the management of non-specific low back pain in primary care. Eur Spine J. 2010;19(12):2075-2094. doi:10.1007/s00586-010-1502-y
    1. Oliveira CB, Maher CG, Pinto RZ, et al. . Clinical practice guidelines for the management of non-specific low back pain in primary care: an updated overview. Eur Spine J. 2018;27(11):2791-2803. doi:10.1007/s00586-018-5673-2
    1. Tucker HR, Scaff K, McCloud T, et al. . Harms and benefits of opioids for management of non-surgical acute and chronic low back pain: a systematic review. Br J Sports Med. 2020;54(11):664. doi:10.1136/bjsports-2018-099805
    1. Lemmers GPG, van Lankveld W, Westert GP, van der Wees PJ, Staal JB. Imaging versus no imaging for low back pain: a systematic review, measuring costs, healthcare utilization and absence from work. Eur Spine J. 2019;28(5):937-950. doi:10.1007/s00586-019-05918-1
    1. Jacobs JC, Jarvik JG, Chou R, et al. . Observational study of the downstream consequences of inappropriate MRI of the lumbar spine. J Gen Intern Med. 2020;35(12):3605-3612. doi:10.1007/s11606-020-06181-7
    1. Mafi JN, McCarthy EP, Davis RB, Landon BE. Worsening trends in the management and treatment of back pain. JAMA Intern Med. 2013;173(17):1573-1581. doi:10.1001/jamainternmed.2013.8992
    1. Kamper SJ, Logan G, Copsey B, et al. . What is usual care for low back pain? a systematic review of health care provided to patients with low back pain in family practice and emergency departments. Pain. 2020;161(4):694-702. doi:10.1097/j.pain.0000000000001751
    1. Delitto A, Patterson CG, Stevans JM, et al. . Study protocol for targeted interventions to prevent chronic low back pain in high-risk patients: a multi-site pragmatic cluster randomized controlled trial (TARGET Trial). Contemp Clin Trials. 2019;82:66-76. doi:10.1016/j.cct.2019.05.010
    1. Hill JC, Dunn KM, Lewis M, et al. . A primary care back pain screening tool: identifying patient subgroups for initial treatment. Arthritis Rheum. 2008;59(5):632-641. doi:10.1002/art.23563
    1. Fairbank JC, Pynsent PB. The Oswestry Disability Index. Spine (Phila Pa 1976). 2000;25(22):2940-2952. doi:10.1097/00007632-200011150-00017
    1. Neighborhood Atlas. Accessed January 11, 2021.
    1. Seaman SR, White IR. Review of inverse probability weighting for dealing with missing data. Stat Methods Med Res. 2013;22(3):278-295. doi:10.1177/0962280210395740
    1. Atlas SJ Management of low back pain: getting from evidence-based recommendations to high-value care. Ann Intern Med. 2017;166(7):533-534. doi:10.7326/M17-0293
    1. Traeger AC, Buchbinder R, Elshaug AG, Croft PR, Maher CG. Care for low back pain: can health systems deliver? Bull World Health Organ. 2019;97(6):423-433. doi:10.2471/BLT.18.226050
    1. George SZ, Goertz C, Hastings SN, Fritz JM. Transforming low back pain care delivery in the United States. Pain. 2020;161(12):2667-2673. doi:10.1097/j.pain.0000000000001989
    1. Buchbinder R, van Tulder M, Öberg B, et al. ; Lancet Low Back Pain Series Working Group . Low back pain: a call for action. Lancet. 2018;391(10137):2384-2388. doi:10.1016/S0140-6736(18)30488-4
    1. Korownyk C, McCormack J, Kolber MR, Garrison S, Allan GM. Competing demands and opportunities in primary care. Can Fam Physician. 2017;63(9):664-668.
    1. Sowden G, Hill JC, Morso L, Louw Q, Foster NE. Advancing practice for back pain through stratified care (STarT Back). Braz J Phys Ther. 2018;22(4):255-264. doi:10.1016/j.bjpt.2018.06.003
    1. Cherkin D, Balderson B, Wellman R, et al. . Effect of low back pain risk-stratification strategy on patient outcomes and care processes: the MATCH randomized trial in primary care. J Gen Intern Med. 2018;33(8):1324-1336. doi:10.1007/s11606-018-4468-9
    1. Day CS, Yeh AC, Franko O, Ramirez M, Krupat E. Musculoskeletal medicine: an assessment of the attitudes and knowledge of medical students at Harvard Medical School. Acad Med. 2007;82(5):452-457. doi:10.1097/ACM.0b013e31803ea860
    1. Finestone AS, Raveh A, Mirovsky Y, Lahad A, Milgrom C. Orthopaedists’ and family practitioners’ knowledge of simple low back pain management. Spine (Phila Pa 1976). 2009;34(15):1600-1603. doi:10.1097/BRS.0b013e3181a96622
    1. Matzkin E, Smith EL, Freccero D, Richardson AB. Adequacy of education in musculoskeletal medicine. J Bone Joint Surg Am. 2005;87(2):310-314. doi:10.2106/00004623-200502000-00011
    1. Allan GM, McCormack JP, Korownyk C, Lindblad AJ, Garrison S, Kolber MR. The future of guidelines: primary care focused, patient oriented, evidence based and simplified. Maturitas. 2017;95:61-62. doi:10.1016/j.maturitas.2016.08.015
    1. Lau R, Stevenson F, Ong BN, et al. . Achieving change in primary care—effectiveness of strategies for improving implementation of complex interventions: systematic review of reviews. BMJ Open. 2015;5(12):e009993. doi:10.1136/bmjopen-2015-009993
    1. Murphy DR, Justice BD, Paskowski IC, Perle SM, Schneider MJ. The establishment of a primary spine care practitioner and its benefits to health care reform in the United States. Chiropr Man Therap. 2011;19(1):17. doi:10.1186/2045-709X-19-17
    1. Fox J, Haig AJ, Todey B, Challa S. The effect of required physiatrist consultation on surgery rates for back pain. Spine (Phila Pa 1976). 2013;38(3):E178-E184. doi:10.1097/BRS.0b013e31827bf40c
    1. Standaert CJ, Li JW, Glassman SJ, et al. . Costs associated with the treatment of low back disorders: a comparison of surgeons and physiatrists. PM R. 2020;12(6):551-562. doi:10.1002/pmrj.12266
    1. van Harten WH Turning teams and pathways into integrated practice units: appearance characteristics and added value. Int J Care Coord. 2018;21(4):113-116. doi:10.1177/2053434518816529
    1. Draugalis JR, Plaza CM. Best practices for survey research reports revisited: implications of target population, probability sampling, and response rate. Am J Pharm Educ. 2009;73(8):142. doi:10.5688/aj7308142
    1. Morton SM, Bandara DK, Robinson EM, Carr PE. In the 21st Century, what is an acceptable response rate? Aust N Z J Public Health. 2012;36(2):106-108. doi:10.1111/j.1753-6405.2012.00854.x
    1. George SZ, Lentz TA, Beneciuk JM, Bhavsar NA, Mundt JM, Boissoneault J. Framework for improving outcome prediction for acute to chronic low back pain transitions. Pain Rep. 2020;5(2):e809. doi:10.1097/PR9.0000000000000809

Source: PubMed

Подписаться